Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2004) 30.40

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89

Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med (2008) 5.89

Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int (2010) 3.78

The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med (2011) 3.20

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05

NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) 2.99

Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl (2006) 2.84

Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant (2012) 2.59

Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology (2013) 2.12

Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol (2010) 1.73

Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI). Nephrol Dial Transplant (2009) 1.65

Insights on urinary NGAL obtained in a primary care setting. Clin Chim Acta (2012) 1.53

Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol (2006) 1.51

Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem (2009) 1.50

The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol (2010) 1.48

Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol (2006) 1.48

Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem (2014) 1.47

Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury. Circ Cardiovasc Interv (2015) 1.45

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA (2003) 1.36

Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol (2011) 1.35

Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) (2013) 1.26

Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology (2010) 1.20

Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography. Angiology (2013) 1.18

Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department. Crit Care (2013) 1.16

Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res (2007) 1.15

Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med (2008) 1.09

NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol (2007) 1.04

Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine (2010) 0.94

Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk. Am J Nephrol (2012) 0.89

Urinary NGAL measurement: biological variation and ratio to creatinine. Clin Chim Acta (2010) 0.87

Contrast-induced nephropathy: is the picture any clearer? Clin J Am Soc Nephrol (2007) 0.86

Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention. Scand J Clin Lab Invest (2013) 0.86

Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. BMC Nephrol (2013) 0.85

Day-to-day variation of urinary NGAL and rational for creatinine correction. Clin Biochem (2012) 0.83

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study). BMC Nephrol (2011) 0.83

Urinary NGAL levels before and after coronary angiography: a complex story. Nephrol Dial Transplant (2011) 0.77